Millennium Management’s Collegium Pharmaceutical COLL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.62M Sell
223,972
-423,860
-65% -$12.5M ﹤0.01% 1893
2025
Q1
$19.3M Buy
647,832
+461,914
+248% +$13.8M 0.01% 1094
2024
Q4
$5.33M Buy
185,918
+51,972
+39% +$1.49M ﹤0.01% 1964
2024
Q3
$5.18M Sell
133,946
-169,924
-56% -$6.57M ﹤0.01% 1961
2024
Q2
$9.78M Buy
303,870
+110,499
+57% +$3.56M ﹤0.01% 1477
2024
Q1
$7.51M Sell
193,371
-250,274
-56% -$9.72M ﹤0.01% 1693
2023
Q4
$13.7M Sell
443,645
-39,328
-8% -$1.21M 0.01% 1277
2023
Q3
$10.8M Buy
482,973
+142,051
+42% +$3.17M 0.01% 1359
2023
Q2
$7.33M Sell
340,922
-243,388
-42% -$5.23M ﹤0.01% 1676
2023
Q1
$14M Buy
584,310
+543,729
+1,340% +$13M 0.01% 1183
2022
Q4
$941K Sell
40,581
-429,094
-91% -$9.95M ﹤0.01% 3212
2022
Q3
$7.52M Buy
469,675
+457,604
+3,791% +$7.33M ﹤0.01% 1862
2022
Q2
$214K Buy
+12,071
New +$214K ﹤0.01% 4426
2021
Q4
Sell
-54,099
Closed -$1.07M 5242
2021
Q3
$1.07M Sell
54,099
-80,638
-60% -$1.59M ﹤0.01% 3573
2021
Q2
$3.19M Buy
134,737
+58,847
+78% +$1.39M ﹤0.01% 2642
2021
Q1
$1.8M Sell
75,890
-105,908
-58% -$2.51M ﹤0.01% 2880
2020
Q4
$3.64M Buy
181,798
+164,648
+960% +$3.3M ﹤0.01% 2127
2020
Q3
$357 Buy
+17,150
New +$357 ﹤0.01% 2990
2020
Q1
Sell
-149,575
Closed -$3.08M 3211
2019
Q4
$3.08M Buy
+149,575
New +$3.08M ﹤0.01% 1866
2019
Q3
Sell
-12,812
Closed -$168K 3536
2019
Q2
$168K Sell
12,812
-55,226
-81% -$724K ﹤0.01% 3254
2019
Q1
$1.03M Sell
68,038
-1,236,963
-95% -$18.7M ﹤0.01% 2400
2018
Q4
$22.4M Buy
1,305,001
+1,169,537
+863% +$20.1M 0.03% 601
2018
Q3
$2M Sell
135,464
-225,571
-62% -$3.33M ﹤0.01% 2147
2018
Q2
$8.61M Buy
361,035
+332,647
+1,172% +$7.93M 0.01% 1289
2018
Q1
$725K Sell
28,388
-37,829
-57% -$966K ﹤0.01% 2643
2017
Q4
$1.22M Sell
66,217
-1,106,580
-94% -$20.4M ﹤0.01% 2390
2017
Q3
$12.3M Buy
1,172,797
+823,208
+235% +$8.64M 0.02% 1046
2017
Q2
$4.37M Buy
349,589
+263,346
+305% +$3.29M 0.01% 1453
2017
Q1
$868K Buy
86,243
+59,875
+227% +$603K ﹤0.01% 2267
2016
Q4
$411K Buy
+26,368
New +$411K ﹤0.01% 2560